# OnCo record r-chop (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/r-chop/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "r-chop" ;
  schema:name "R-CHOP (lymphoma chemoimmunotherapy)"@en ;
  schema:alternateName "R-CHOP"@en, "R-CHOP21"@en, "CHOP-R"@en, "Pola-R-CHP"@en, "polatuzumab-R-CHP"@en, "R-CHOEP"@en, "DA-EPOCH-R"@en, "R-CVP"@en, "bendamustine-rituximab"@en, "chemoimmunotherapy"@en, "chemo-immunotherapy regimen"@en, "R-ICE"@en, "R-DHAP"@en, "R-GDP"@en ;
  schema:description "R-CHOP is the standard first treatment for diffuse large B-cell lymphoma: rituximab (an antibody against CD20) plus four chemotherapy drugs (cyclophosphamide, doxorubicin, vincristine, prednisone), given every three weeks for six cycles with curative intent. Patients who relapse within a year now go to CAR-T rather than more chemotherapy."@en ;
  schema:url <https://onco.cc/terms/r-chop/> ;
  schema:dateModified "2026-09-09"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/R-CHOP> ;
  schema:citation <https://en.wikipedia.org/wiki/R-CHOP> ;
  onco:related <https://onco.cc/terms/anthracycline/>, <https://onco.cc/terms/deauville/>, <https://onco.cc/terms/salvage-therapy/>, <https://onco.cc/terms/chemotherapy-regimen/> ;
  onco:cancers <https://onco.cc/cancers/dlbcl/>, <https://onco.cc/cancers/cll/> ;
  onco:sections <https://onco.cc/fronts/chemotherapy/>, <https://onco.cc/fronts/immunotherapy/> ;
  onco:drugs <https://onco.cc/drugs/rituximab/>, <https://onco.cc/drugs/cyclophosphamide/>, <https://onco.cc/drugs/doxorubicin/>, <https://onco.cc/drugs/vincristine/>, <https://onco.cc/drugs/bendamustine/> .